BRPI0512756A - composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas - Google Patents

composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas

Info

Publication number
BRPI0512756A
BRPI0512756A BRPI0512756-4A BRPI0512756A BRPI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pain
capsules
control method
including tablets
Prior art date
Application number
BRPI0512756-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of BRPI0512756A publication Critical patent/BRPI0512756A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0512756-4A 2004-07-07 2005-07-07 composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas BRPI0512756A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
PCT/NZ2005/000168 WO2006004449A2 (en) 2004-07-07 2005-07-07 A combination composition

Publications (1)

Publication Number Publication Date
BRPI0512756A true BRPI0512756A (pt) 2008-04-08

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512756-4A BRPI0512756A (pt) 2004-07-07 2005-07-07 composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas

Country Status (21)

Country Link
US (4) US20080275125A1 (enExample)
EP (1) EP1781277B1 (enExample)
JP (1) JP5630943B2 (enExample)
KR (1) KR101370712B1 (enExample)
CN (1) CN101022789A (enExample)
AT (1) ATE543491T1 (enExample)
AU (2) AU2005260243B2 (enExample)
BR (1) BRPI0512756A (enExample)
CA (1) CA2570474C (enExample)
CY (2) CY1112738T1 (enExample)
DK (1) DK1781277T3 (enExample)
ES (1) ES2381794T3 (enExample)
GB (1) GB2431346C (enExample)
LT (1) LTC1781277I2 (enExample)
MX (1) MX2007000117A (enExample)
PL (1) PL1781277T3 (enExample)
PT (1) PT1781277E (enExample)
RU (2) RU2007101686A (enExample)
SI (1) SI1781277T1 (enExample)
WO (1) WO2006004449A2 (enExample)
ZA (1) ZA200700896B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5630943B2 (ja) 2004-07-07 2014-11-26 エイ・エフ・ティ・ファーマスーティカルズ・リミテッドＡｆｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ 複合剤組成物
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
CN101563074B (zh) 2006-10-20 2012-11-07 麦克内尔-Ppc股份有限公司 乙酰氨基酚/布洛芬组合
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
WO2009012590A1 (en) * 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
WO2009083759A1 (en) * 2008-01-03 2009-07-09 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
KR20110112279A (ko) * 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
MY164112A (en) * 2010-07-07 2017-11-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
LT2635269T (lt) * 2010-11-04 2019-09-10 Aft Pharmaceuticals Limited Derinio kompozicija
AU2012253834B2 (en) * 2011-05-06 2016-06-16 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Sustained release paracetamol formulations
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
AU2018300075B2 (en) 2017-07-10 2024-02-29 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
KR20220027194A (ko) 2019-06-27 2022-03-07 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 신규 이부프로펜 및 아세트아미노펜 조성물
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
JP5630943B2 (ja) 2004-07-07 2014-11-26 エイ・エフ・ティ・ファーマスーティカルズ・リミテッドＡｆｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ 複合剤組成物
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
KR20110112279A (ko) 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료

Also Published As

Publication number Publication date
AU2008202029A1 (en) 2009-11-26
CY2023026I1 (el) 2024-02-16
LTC1781277I2 (enExample) 2024-07-10
WO2006004449A2 (en) 2006-01-12
MX2007000117A (es) 2007-06-15
US20080200549A1 (en) 2008-08-21
ZA200700896B (en) 2008-07-30
GB2431346B (en) 2010-01-27
GB2431346C (en) 2010-02-17
ES2381794T3 (es) 2012-05-31
EP1781277A2 (en) 2007-05-09
CY2023026I2 (el) 2025-03-28
RU2010147287A (ru) 2012-05-27
DK1781277T3 (da) 2012-05-07
EP1781277A4 (en) 2008-09-03
JP5630943B2 (ja) 2014-11-26
RU2455983C1 (ru) 2012-07-20
CA2570474C (en) 2010-01-05
AU2005260243B2 (en) 2009-10-29
KR101370712B1 (ko) 2014-03-06
LTPA2024501I1 (enExample) 2024-02-12
AU2005260243A1 (en) 2006-01-12
CA2570474A1 (en) 2006-01-12
EP1781277B1 (en) 2012-02-01
WO2006004449A3 (en) 2006-03-02
US20080275125A1 (en) 2008-11-06
RU2007101686A (ru) 2008-08-20
JP2008505889A (ja) 2008-02-28
PT1781277E (pt) 2012-05-07
CN101022789A (zh) 2007-08-22
KR20070034614A (ko) 2007-03-28
GB0700027D0 (en) 2007-02-07
ATE543491T1 (de) 2012-02-15
GB2431346A (en) 2007-04-25
SI1781277T1 (sl) 2012-07-31
US20140073696A1 (en) 2014-03-13
US10532036B2 (en) 2020-01-14
CY1112738T1 (el) 2016-02-10
US20110275718A1 (en) 2011-11-10
PL1781277T3 (pl) 2012-07-31

Similar Documents

Publication Publication Date Title
BRPI0418228A (pt) forma de dosagem, e, métodos de tratamento de dor e de episódios de dor incidente de cáncer, e de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
GB0222514D0 (en) Organic compounds
DK1140031T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof
EA200401097A1 (ru) Лекарственная форма с регулируемым высвобождением активного ингредиента
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
MX2021010338A (es) Composicion farmaceutica que contiene acetominofeno e ibuprofeno.
MA31227B1 (fr) Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
SE0203817D0 (sv) New composition
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
BRPI0416691A (pt) forma de preparação farmacêutica sólida
CL2010000738A1 (es) Suspension farmaceutica oral que comprende desde 100 hasta 500 mg/5ml de paracetamol, desde 40 hasta 80 mg/5ml de ibuprofeno o desde 200 hasta 400 mg/5ml de paracetamol, desde 100 hasta 200 mg/5ml de ibuprofeno y uno o mas excipientes farmaceuticamente aceptables, util para tratar el dolor pre, peri o postoperatorio.
AR033876A1 (es) Un envase o "pack" que facilita la adecuada dosificacion y el cumplimiento del tratamiento y las asociaciones provistas en dicho envase
IL162857A0 (en) Oral vaccination
AR052993A1 (es) Composicon farmaceutica que contiene zofenopril y hctz para el tratamiento de la hipertension
ECSP003634A (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante, medicamentos que contienen estas sales, el uso de estas sales para la preparacion de medicamentos y formas de administracion que contienen estas sales
MY154883A (en) A combination composition

Legal Events

Date Code Title Description
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA PETICAO NO 018110026680 DE 13/07/2011 EM VIRTUDE DOS DISPOSTO NO ARTIGO 219, INCISO II,DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B15W Others matters related to applications: legal action concerning application

Free format text: INPI NO 52402.012101/2022-18 ORIGEM: 9A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5080684-80.2022.4.02.5101/RJ NULIDADE DE ATO ADMINISTRATIVO AUTOR: AFT PHARMACEUTICALS LIMITED REU(S): INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL